Back to search
Nonmuscle-invasive Bladder Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Nonmuscle-invasive Bladder Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Nonmuscle-invasive Bladder Cancer trials you may qualify forIntravesical immunotherapy or chemotherapy for non-muscle invasive bladder cancer (NMIBC) is a well-established treatment for preventing or delaying tumor recur…
This is a Phase II clinical study to evaluate the efficacy and safety of intravesical T3011 injection in participants with BCG-unresponsive high-risk NMIBC or B…
This expanded access protocol is designed to provide Recombinant Mycobacterium BCG (rMBCG) to patients with Non-muscle invasive bladder cancer (NMIBC) who are e…
The purpose of this study is to evaluate patient-reported preference for urine based molecular testing (CxBladder Monitor) compared to cystoscopy for patients o…
This randomized controlled trial will evaluate the efficacy of three bladder irrigation solutions - distilled water (DW), normal saline (NS), and hypertonic sal…